1. Home
  2. THRD vs CVEO Comparison

THRD vs CVEO Comparison

Compare THRD & CVEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • CVEO
  • Stock Information
  • Founded
  • THRD 2019
  • CVEO 1977
  • Country
  • THRD United States
  • CVEO United States
  • Employees
  • THRD N/A
  • CVEO N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • CVEO Hotels/Resorts
  • Sector
  • THRD Health Care
  • CVEO Consumer Discretionary
  • Exchange
  • THRD Nasdaq
  • CVEO Nasdaq
  • Market Cap
  • THRD 238.7M
  • CVEO 281.2M
  • IPO Year
  • THRD 2022
  • CVEO N/A
  • Fundamental
  • Price
  • THRD $5.46
  • CVEO $24.11
  • Analyst Decision
  • THRD Hold
  • CVEO Strong Buy
  • Analyst Count
  • THRD 3
  • CVEO 1
  • Target Price
  • THRD $5.00
  • CVEO $27.00
  • AVG Volume (30 Days)
  • THRD 220.4K
  • CVEO 79.8K
  • Earning Date
  • THRD 08-07-2025
  • CVEO 07-29-2025
  • Dividend Yield
  • THRD N/A
  • CVEO 3.12%
  • EPS Growth
  • THRD N/A
  • CVEO N/A
  • EPS
  • THRD N/A
  • CVEO N/A
  • Revenue
  • THRD N/A
  • CVEO $660,046,000.00
  • Revenue This Year
  • THRD N/A
  • CVEO N/A
  • Revenue Next Year
  • THRD N/A
  • CVEO $4.45
  • P/E Ratio
  • THRD N/A
  • CVEO N/A
  • Revenue Growth
  • THRD N/A
  • CVEO N/A
  • 52 Week Low
  • THRD $3.18
  • CVEO $18.01
  • 52 Week High
  • THRD $16.02
  • CVEO $28.92
  • Technical
  • Relative Strength Index (RSI)
  • THRD 66.73
  • CVEO 63.62
  • Support Level
  • THRD $5.42
  • CVEO $23.47
  • Resistance Level
  • THRD $5.45
  • CVEO $24.59
  • Average True Range (ATR)
  • THRD 0.04
  • CVEO 0.63
  • MACD
  • THRD -0.01
  • CVEO 0.09
  • Stochastic Oscillator
  • THRD 50.00
  • CVEO 84.19

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.

Share on Social Networks: